<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xmlns:dc="http://purl.org/dc/elements/1.1/">
  <title>DSpace Collection:</title>
  <link rel="alternate" href="http://repository.usmf.md:80/handle/20.500.12710/33822" />
  <subtitle />
  <id>http://repository.usmf.md:80/handle/20.500.12710/33822</id>
  <updated>2026-11-21T03:58:44Z</updated>
  <dc:date>2026-11-21T03:58:44Z</dc:date>
  <entry>
    <title>Transscleral cyclophotocoagulation: a novel integrated system for assessing thermal efficiency and safety</title>
    <link rel="alternate" href="http://repository.usmf.md:80/handle/20.500.12710/34793" />
    <author>
      <name>Guzun, Olga</name>
    </author>
    <author>
      <name>Zadorozhnyy, Oleg</name>
    </author>
    <author>
      <name>Osadchuk, Petro</name>
    </author>
    <author>
      <name>Vychuzhanin, Volodymyr</name>
    </author>
    <author>
      <name>Khomenko, Andrii</name>
    </author>
    <author>
      <name>Korol, Andriy</name>
    </author>
    <id>http://repository.usmf.md:80/handle/20.500.12710/34793</id>
    <updated>2026-11-19T09:17:07Z</updated>
    <published>2026-01-01T00:00:00Z</published>
    <summary type="text">Title: Transscleral cyclophotocoagulation: a novel integrated system for assessing thermal efficiency and safety
Authors: Guzun, Olga; Zadorozhnyy, Oleg; Osadchuk, Petro; Vychuzhanin, Volodymyr; Khomenko, Andrii; Korol, Andriy
Abstract: Introduction/Objectives. Optimization of transscleral cyclophotocoagulation&#xD;
requires an objective assessment of tissue thermal response, as maximum&#xD;
temperature alone does not adequately characterize treatment efficacy and safety.&#xD;
This study aimed to develop an integrated system for quantitative evaluation of&#xD;
tissue thermal response based on mathematical modeling.&#xD;
Materials and Methods. A mathematical heat-transfer model of the ciliary body&#xD;
during 810-nm transscleral cyclophotocoagulation was developed to simulate the&#xD;
spatiotemporal distribution of tissue temperature under different laser settings.&#xD;
Based on the simulated thermal profiles, an integrated system of thermal indices&#xD;
was proposed, including the Thermal Efficiency Index (TEI), Destructive Energy&#xD;
Index (DEI), Thermal Selectivity Index (TSI), Safety Margin, and Thermal&#xD;
Accumulation Index (TAI).&#xD;
Results. The proposed integrated indices provided a comprehensive quantitative&#xD;
assessment of therapeutic efficiency, laser selectivity, thermal accumulation, and&#xD;
the risk of destructive thermal injury. Unlike conventional evaluation based solely&#xD;
on peak temperature, the integrated indices characterized the entire&#xD;
spatiotemporal thermal profile during laser exposure. Laser settings of up to 2.0&#xD;
W achieved the therapeutic temperature range, whereas increasing energy&#xD;
delivery was associated with progressive thermal accumulation and a higher risk&#xD;
of destructive tissue heating. The integrated assessment enabled identification of&#xD;
the transition between therapeutic and potentially destructive thermal effects.&#xD;
Conclusions. The proposed integrated thermal assessment system expands the&#xD;
capabilities of mathematical modeling for transscleral cyclophotocoagulation by&#xD;
providing an objective evaluation of treatment efficiency and safety. This&#xD;
approach may support personalized optimization of laser parameters and improve&#xD;
clinical planning of glaucoma treatment.</summary>
    <dc:date>2026-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Cumulative burden index as a novel tool for long-term assessment of treatment outcomes in secondary neovascular glaucoma</title>
    <link rel="alternate" href="http://repository.usmf.md:80/handle/20.500.12710/34792" />
    <author>
      <name>Guzun, Olga</name>
    </author>
    <author>
      <name>Zadorozhnyy, Oleg</name>
    </author>
    <author>
      <name>Korol, Andriy</name>
    </author>
    <id>http://repository.usmf.md:80/handle/20.500.12710/34792</id>
    <updated>2026-11-19T08:52:20Z</updated>
    <published>2026-01-01T00:00:00Z</published>
    <summary type="text">Title: Cumulative burden index as a novel tool for long-term assessment of treatment outcomes in secondary neovascular glaucoma
Authors: Guzun, Olga; Zadorozhnyy, Oleg; Korol, Andriy
Abstract: Introduction/Objectives. Secondary neovascular glaucoma requires multiple&#xD;
therapeutic interventions, yet conventional outcome measures do not reflect&#xD;
cumulative treatment burden. This study evaluated the prognostic value of the&#xD;
Cumulative Burden Index (CBI) for long-term treatment outcomes.&#xD;
Materials and Methods. This prospective study included 224 eyes with&#xD;
secondary neovascular glaucoma treated with transscleral cyclophotocoagulation&#xD;
and followed for 36 months. The Cumulative Burden Index was calculated as an&#xD;
integrated measure incorporating the number of cyclophotocoagulation&#xD;
procedures and the severity of clinical complications. The prognostic&#xD;
performance of CBI was evaluated using multivariable logistic regression and&#xD;
receiver operating characteristic (ROC) analysis.&#xD;
Results. At 36 months, treatment success was achieved in 155 eyes (69.2%),&#xD;
whereas 69 eyes (30.8%) were classified as treatment failures. The mean CBI was&#xD;
significantly lower in the successful treatment group than in the failure group (3.9&#xD;
vs. 6.6 points; p &lt; 0.001). In the multivariable logistic regression model, CBI&#xD;
remained an independent predictor of unfavorable treatment outcome (OR = 1.58;&#xD;
95% CI, 1.32–1.90; p &lt; 0.001). ROC analysis demonstrated good&#xD;
predictive performance (AUC = 0.84; 95% CI, 0.79–0.89). A CBI&#xD;
threshold of ≥5 yielded a sensitivity of 78% and a&#xD;
specificity of 81%.&#xD;
Conclusions. The Cumulative Burden Index is an independent predictor of longterm treatment outcomes in secondary neovascular glaucoma. Quantification of&#xD;
cumulative treatment burden using CBI may improve risk stratification, facilitate&#xD;
personalized treatment planning, and support clinical decision-making in patients&#xD;
with secondary neovascular glaucoma.</summary>
    <dc:date>2026-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Trabeculoplastia – opțiune terapeutică în tratamentul glaucomului</title>
    <link rel="alternate" href="http://repository.usmf.md:80/handle/20.500.12710/34790" />
    <author>
      <name>Celac, Irina</name>
    </author>
    <author>
      <name>Lobcenco, Aglaia</name>
    </author>
    <id>http://repository.usmf.md:80/handle/20.500.12710/34790</id>
    <updated>2026-11-19T08:43:24Z</updated>
    <published>2026-01-01T00:00:00Z</published>
    <summary type="text">Title: Trabeculoplastia – opțiune terapeutică în tratamentul glaucomului
Authors: Celac, Irina; Lobcenco, Aglaia
Abstract: Introducere: Introducerea trabeculoplastiei laser cu argon în practica&#xD;
oftalmologică oferă o alternativă terapeutică eficientă pentru pacienții cu glaucom&#xD;
cu unghi deschis, contribuind la reducerea presiunii intraoculare și la optimizarea&#xD;
managementului antiglaucomatos.&#xD;
Materiale si metode: Studiul a inclus 45 pacienți cu glaucom primar cu unghi&#xD;
deschis, la care s-a efectuat trabeculoplastia laser, evaluându-se eficacitatea&#xD;
acesteia prin monitorizarea tensiunii intraoculare și a parametrilor oftalmologici&#xD;
îndecurs de 2 ani.&#xD;
Rezultate: Rezultatele au evidențiat o reducere a tensiunii intraoculare după&#xD;
efectuarea trabeculoplastiei laser, cu menținerea efectului hipotensiv la 85% din&#xD;
pacienți pe parcursul perioadei de monitorizare.&#xD;
Concluzii: Trabeculoplastia poate fi considerate ca metodă intermediară între&#xD;
tratamentul medicamentos și cel chirurgical al glaucomului cu unghi deschis.</summary>
    <dc:date>2026-01-01T00:00:00Z</dc:date>
  </entry>
  <entry>
    <title>Chirurgia glaucomului refractar în pseudofachie</title>
    <link rel="alternate" href="http://repository.usmf.md:80/handle/20.500.12710/34788" />
    <author>
      <name>Celac, Irina</name>
    </author>
    <author>
      <name>Lobcenco, Aglaia</name>
    </author>
    <author>
      <name>Bendelic, Eugeniu</name>
    </author>
    <id>http://repository.usmf.md:80/handle/20.500.12710/34788</id>
    <updated>2026-11-19T08:28:47Z</updated>
    <published>2026-01-01T00:00:00Z</published>
    <summary type="text">Title: Chirurgia glaucomului refractar în pseudofachie
Authors: Celac, Irina; Lobcenco, Aglaia; Bendelic, Eugeniu
Abstract: Introducere: Glaucomul refractar la pacienții cu Artifachie reprezintă o&#xD;
provocare terapeutică majoră. Scleroanguloreconstrucția oferă o alternativă&#xD;
chirurgicală eficientă pentru controlol presiunii intraoculare și conservarea&#xD;
funcției vizuale.&#xD;
Materiale si metode: Acestă variantă de trabeculectomie SAR o practicăm, mai&#xD;
frecvent, timp de ultimii ani și am aplicat-o la un lot de 21 pacienți cu glaucom&#xD;
refractar cu implant de PF, PIO variind între 33-43 mmHg, vârsta 50-68 ani. În&#xD;
timpul intervenţiei necesită o deosebită atenţie în separarea voletului scleral doi,&#xD;
în unele cazuri voletul este unul subţire şi poate fi traumat. Alte complicaţii în&#xD;
timpul operaţiei nu am observat. În perioada postoperatorie precoce în 2 cazuri&#xD;
am avut hipotonie (până la 12 mmHg) și un caz atalamia camerei anterioare.&#xD;
Ambele complicații la momentul externării au fost înlăturate. Hifemă, decolare&#xD;
de coroidă nu am observat.&#xD;
Rezultate: Termenul de observație a fost 1 an. În majoritatea cazurilor evoluția a&#xD;
fost relativ areactivă. Dinamica PIO în perioada postoperatorie precoce a fost în&#xD;
limitele 16.0±2mmHg fără medicație medicamentoasă; la distanța de 6 luni PIO&#xD;
varia între 19.5±2mmHg, iar la distanța de 1 an PIO s-a înregistrat&#xD;
compensată(19.0±2mmHg) fără medicație la 13 – 61,9% pacienți pe fon de&#xD;
tratement medicamentos 6 – 28,6% și la 2 – 9,5% pacienți pe fon de tratament&#xD;
medicamentos PIO subcompensată.&#xD;
Concluzii: Operația SAR în chirurgia glaucomului refractiv aduce un efect&#xD;
hipotensiv stabil 90,5%. În comparație cu 7 alte tehnici operatorii înregistrează&#xD;
un număr mai mic de complicații intra- și postoperatorii.</summary>
    <dc:date>2026-01-01T00:00:00Z</dc:date>
  </entry>
</feed>

